Aquestive Therapeutics, Inc. SEC filings AQST

Aquestive Therapeutics, Inc. has 686 filings in SEC EDGAR's recent list, going back to May 14, 2007. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Apr 24, 2026 Dec 31, 2025
10-K Annual report Mar 4, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 25, 2025 Dec 31, 2024
10-K Annual report Mar 5, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 26, 2024 Dec 31, 2023
10-K Annual report Mar 5, 2024 Dec 31, 2023
ARS Annual report to shareholders May 2, 2023 Dec 31, 2022
10-K Annual report Mar 31, 2023 Dec 31, 2022
10-K Annual report Mar 8, 2022 Dec 31, 2021
10-K Annual report Mar 9, 2021 Dec 31, 2020
10-K Annual report Mar 11, 2020 Dec 31, 2019
10-K Annual report Mar 14, 2019 Dec 31, 2018

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
AQST (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Warren, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1398733
Former names
MonoSol Rx, Inc. (until Mar 27, 2008)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.